News of Note—Attune Medical bags $10M; Abbott debuts neurostimulator for complex regional pain syndrome


> Attune Medical raised $10 million in series C financing for its esophageal temperature management devices. Release

> Abbott launched a new neurostimulator, the Proclaim DRG system, which treats complex regional pain syndrome of the lower limbs by stimulating the dorsal root ganglion. Release

> One Drop unveiled its diabetes management program, based on its wireless blood glucose monitoring system, which it plans to launch in 2018. Release | Read more about One Drop


Overcoming Risk in Oncology Drug Development

Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Download this whitepaper for tips on finding the fast track. Premier Research. Built for Biotech.

Suggested Articles

The FDA approved the first spinal tether to correct the most common form of scoliosis—a ropelike implant that pulls the vertebrae into shape.

Agilent launched a new analyzer for research that observes cell behavior in real time while also collecting biosensor information.

Five years after Congress passed a law to reduce unnecessary MRIs and CT scans, federal officials have yet to implement it.